The Pharmaceutical Portfolio Management Outlook: Integrated decision-making in marketing and R&D

Executive Summary

The application and definition of portfolio management has evolved greatly over the past 20 years; the impact of rising R&D costs and falling productivity levels has led companies to pay far greater attention to their portfolio strategies, resource allocation and decision-making. Today, no major pharmaceutical or biotechnology company is without some centralized portfolio management function with wide ranging responsibilities including strategy development, investment appraisal and resource allocation. However, those most affected by portfolio management continue to be the executives in R&D and marketing with the responsibility to deliver successful projects and leading products in order to generate the high levels of return on investment required by shareholders. The new management report Pharmaceutical Portfolio Management: Integrated decision-making in marketing and R&D, presents a comprehensive overview of effective portfolio management processes, with a focus on better preparing senior management, R&D and marketing executives for integrated decision-making across the organization as a whole. Utilise this new report to improve product lifecycle decisions and ensure the right people are involved in making the right decisions, at the right time. Effective portfolio management will generate greater efficiencies, reduce costs and will ultimately increase profits.